You do know that this is a last hope drug? The risk is dying on schedule.
On Mon, Aug 16, 2010 at 2:31 PM, G Money <[email protected]> wrote: > > "Contrary to initial research, new studies indicate that the benefits of the > drug, which costs $8,000 a month, do not outweigh its risks, the advisory > panel concluded." > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~| Order the Adobe Coldfusion Anthology now! http://www.amazon.com/Adobe-Coldfusion-Anthology-Michael-Dinowitz/dp/1430272155/?tag=houseoffusion Archive: http://www.houseoffusion.com/groups/cf-community/message.cfm/messageid:325113 Subscription: http://www.houseoffusion.com/groups/cf-community/subscribe.cfm Unsubscribe: http://www.houseoffusion.com/groups/cf-community/unsubscribe.cfm
